Llanos, Anastacio C.
HRN: 22-55-99 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/05/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
02/05/2023
02/11/2023
IVT
4.5 G
Q8
Tetanus Infection; T/c CAP-MR, UTI
Waiting Final Action
Indication: EmpiricEmpirical Escalation Type of Infection: Urinary TractPneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes